← Open Payments lookup

TERRY PRITT: Open Payments

NPI 1144246620 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$317 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $317

Food & beverage: $317
CompanyPaymentsAmount
Almatica Pharma LLC3$65
Collegium Pharmaceutical, Inc.2$54
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Alkermes, Inc.1$29
Otsuka America Pharmaceutical, Inc.1$23
Teva Pharmaceuticals USA, Inc.1$22
Otsuka Pharmaceutical Development & Commercialization, Inc.1$21
Neurocrine BioSciences, Inc.1$16
Supernus Pharmaceuticals, Inc.1$15
E.R. Squibb & Sons, L.L.C.1$14

Products named: LOREEV XR, Jornay PM, CAPLYTA, LYBALVI, REXULTI, AUSTEDO XR, INGREZZA, Qelbree.

Industry payments across MD — which companies pay providers there.